D
BioVaxys Technology Corp. BIOV
CNSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

07/31/2024 04/30/2024 01/31/2024 10/31/2023 07/31/2023
Net Income 65.38% 45.93% 36.21% 25.73% -129.74%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -75.59% -60.61% -44.64% -34.31% 1,283.50%
Change in Net Operating Assets -17.72% 52.71% 11.24% 19.66% -48.61%
Cash from Operations 33.46% 65.25% 51.43% 36.78% 44.36%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 89.91% 32.50% 18.26% -19.09% -26.51%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- 92.62%
Cash from Financing 90.60% 31.91% 15.50% -21.37% -15.78%
Foreign Exchange rate Adjustments 106.51% 84.25% -126.32% -119.05% -156.52%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 1,414.49% 255.04% 1,190.12% 70.91% 95.02%
Weiss Ratings